;

`wes
`es
`A
`2 Bos & Farsme tha rmossetio me feae cyl spycen yr}
`CNiSZ3595A Composite mcodicine for giancomya
`
`x
`
`SAOT SHSRSASTE
`
`Claims
`Drawings
`Original document
`Citations
`Legal evenis
`
`
`
`The present invention relates to a pharmaceutical composition for treating fundus diseases,
`and more particularly to a oharmaceulical composition for treating glaucoma prepared fram
`plant Chinese herbal medicine.
`
`Glaucoma ts an eye disease with elevated pathological pressure associated with visual
`field, vision, and optic nerve damage. The disease is mainly caused by continuous increase
`in intraocular pressure, which gradually shrinks with the optic nerve, shrinks the visualfield,
`and reduces vision. lt often leads to blindness and is one of the most harmful and mainly
`blinded eve diseasss. The green wind cataract and the blue wind cataract mentioned by
`Chinese medicine are similar to glaucoma. The motherland medicine believes that the
`pathogenesis of the Qingfeng cataract is caused by depression and anger, causing liver ai
`stagnation, unfavorable meridians, liver stagnation and fire, and the wind and fire disturbing
`the eyes and causing qi and bload disharmony. The water stagnates and is the disease.
`When the blue wind cataract is anset, the patient is unconscicus or stunned slightly, and
`looks too long. It can be heavy, tired, and
`
`painful. H looks like a rainbowaround the lights. The initial visual acuityts infact, ihe white
`eyes, the black eyes, and the sacred gods are the same; those who are seriously il, the
`sacred gods are medium and large, and the sacredness is weak. The temperament of the
`gadis is slightly cyan, the eyes are slightly hard, and the eyes are fainting. Il can also be
`seen that the wheel is reddish and the surface of the black eye is covered wilh mist. The
`fundus can be changed in the early stage of the fundus, and then the central vascular af the
`niople is slightly displaced to the nasal side. The nippie depression is deepened and
`enlarged, and the nipple vessels are moved to the edge of the optic papilla, which is a knee-
`climbing shape, and the nipple becomes pale and visible. The gray dots of the board. The
`green wind cataract is suddenly onset, and if can also be a "cure wind and severe disease"
`(Criminal Rule, Seven Doors"). The disease is extremelyfierce, the head is severely
`
`

`

`painful, the bead is splitting, and the vision is rapidly falling. The cause is mainly due to
`sorrow and sorrow, violent anger, gas in the liver, ai occlusion, venting dereliction of duty,
`yin and yin, from the liver to the gallblacicer, the liver and gallbladder are blazing, the fire is
`full of wind, the fire is scattered, The hurricane is blazing, the wind and fire are disturbing,
`and itis an the eye. The green wind calaraci often attacks aller anger or tredness. From
`the beginning, the eyeball is slightly swollen, the frontal angie is partial pain, the head is
`dizzy, and the nose is painful. In severe cases, the eyes are painful and cracked, and the
`headache is like soutum, The swelling is implicated in the eyes and the forehead and
`cheeks. The vision is rapidly decreasing. Although il is different from the symptoms af
`Qingfeng cataract, its incidence is related to the adverse effects of the slagnation. In the
`treatment of glaucoma, Western medicine is mainly based on surgical treatment. For
`patienis who are not suilable for surgery for other reasons, eye drops 1%-2%pilocarpine
`eye crops are used to reduce iniraocular pressure and relieve symptoms. Surgery is mare
`fearful, so itis not necessaryto do sa. itis generally unwilling to undergo surgery.
`Ghemicals such as pilocarpine cannot fundamentally sliminate the pathogenic factors of
`glaucoma. Therefore, itis not the best drug choice. in clinical treatment, traditional Chinese
`medicine uses Danshen, scorpion, licarice, angelica, mecdiar, white peony, Atractylodes,
`and Bupleurum, which are made by Dan Xiaoyao (see "Medical Abstract"), or by gentian,
`habitat, angelica, Longdan Xiegan Decoction composed of Bupleurum, Mutong, Alisma,
`Psyllium, Radix Scutellariae, Radix Astragall, and Licarice (see “Ui Zong Jin Jian") for
`treatment, but the effect is not very satisfactory.
`
`itis an object of the present invention to provide a pharmaceutical composition whichis
`effective and which substantially eliminates its causative factors.
`
`The object of the present invention is achieved in this way, based on the pathogenesis and
`treatment principles of glaucoma {ie, green wind dysfunction, bleu cataract) in the
`motherland medicine, and the use of clearing heat and purging fire, soothing liver and wind,
`and reducing fire, Overcast and fire. According to the weight, 10-30 paris of Dendrobium,
`10-30 paris of white peany, 10-30 parts of Ophiopogon, 10-30 parts of mediar, 15-45 parts
`of Cassia, 10-30 parts of psyilum 10-30 parts of Scraphulariaceae, 10-30 parts of
`OQingxiangz!, 10-30 parts of Mi Menghua, 10-30 paris of night sand, 5-25 paris of licorice,
`15-45 paris of Uncaria, and Cassia 15-45 Paris, magnets 15-45 parts, chrysanthemum 10-
`30 parts.
`
`Preferred weight ratios of the invention are:
`
`15-20 parts of Dendrobium, 15-20 parts of while peony, 20-30 paris of Ophiopagon
`japonicus, 20-30 parts of mecdiar, 25-30 parts of Cassia, 15-20 parts of Uncaria, 15-20 parts
`of riagnel, 20-30 parts of chrysanthemum, 30-45 paris of Cassia, 10-20 parts of psyillum,
`20-3) parts of Scrophularia, 15-20 paris of Gingxiangzi, 20-30 parts of dense flawer, 20-30
`Of night sand Serve, 20-25 parts of Hcorice.
`
`

`

`The medicament of the present invention can be prepared into various oral preparations
`such as tablets, capsules, oral liquids, and granules.
`
`The method for preparing the medicament of the present invention into a capsule is:
`
`1. According io the ralic of the compasilion af the present invention, the components are
`
`weighed, soaked in water for 2-4 hours, bolled for 1-2 hours, filtered, and the two filtrates
`are cambined, and the filtrate is concentrated under vacuum to a thick paste, dried, and
`pulverized. The fine powder is passed through a mesh of 80 mesh - 100 mesh, and then
`divided into capsules, each coniaining 0.3 g of pawder.
`
`The dosage of the capsule prepared by the medicament of the invention in the treatment of
`glaucoma is: four capsules each time, three times a day, for three consecutive weeks as a
`course of treaiment.
`
`An important innovation of the present invention is the screening of the combined
`pharmaceutical components with good synergistic effects. The medicine of the invention
`adopts the hook vine, ihe grass cassia, the chrysanthemum, the Pinggan breeze, and at the
`same time, the stone cassia, ihe psylium, the night sand, the licorice are ail laken into the
`ohiegm anc bioad for the bload, accompanied by the scrophularia, the green Phases,
`densely scented flowers, mediar, Ophiopogon japonicus, magnets fo nourish yin and
`maisten the lungs, and the choice of Dangwuwu, Baiqi, so thal its drugs nave the effect of
`regulating bload, liver and liver. Various medicines cooperate with clearing heat, calming
`the liver, and venting the wind, so that the blue wind dysfunction has the effect of bottoming
`
`Out.
`
`The dosage ratio of each carmponent of the drug of the present invention is determined by
`long-term repeated experimental screening. Hf ensures that the drug of the present invention
`has the characteristics of high efficacy and long-lasting effect.
`
`The preferred ratio of the components of the present invention allows for better synergyof
`the components.
`
`The beneficial effects of the pharmaceutical compositions of the invention were verified by
`systematic clinical observation of 132 patients.
`
`The method for verifying the efficacy of the drug of the present invention is:
`
`

`

`132 patients with clinical glaucoma diagnoslic criteria were selected (dlagnostlic crileria are
`published in the Peaple’s Miltary Medical Publishing House, and the General Lagistics
`Department of the Peapie’s Liberation Army compiled the "Clinical Disease Diagnosis
`Based on Cure improvement Standards")
`
`Efficacy criteria:
`
`Gure: anterior chamber recovery, symptoms cisappear, and intraocular pressure drops to
`normal.
`
`Better: The intraocular pressure is iower than before.
`
`irivalid: Clinical symptoms have not improved.
`
`The experimental results are shown in the following table:
`
`The following are specific embodirnenis of the invention.
`
`Exampie 1:
`
`Weighing 30kg of Dendrobium, 1Okg of white peony, 20kg of oyster, 2Okg of mediar, 45kg
`of cassia, 15kg of Uncaria, 20kg of magnet, 2O0kg of chrysanthemum, 15kq of cassia, 20kg
`of osyllium, G0kg of scrophularia, and blue phase 15kg, 2Omm of dense Hower, 15kq of
`mght sand, 20kq of licarice, mix various medicines, soak for 2 hours with water, boil for 1
`hour, filer, medicinal solution, add water and decoct for 1 hour, combine two filtrates.
`
`Concentrate to a thick paste, dry, pulverize into a fine sowder, pass through a SO mesh
`sieve, and dispense 0.3 g of extract powder per capsule.
`
`The following Examples 2-6 were prepared in the same manner as in Example 1, except
`that the proportions of the cornpanents were different, but the objects and effects of the
`present invention were achieved.
`
`Example 2-8:
`
`

`

`[19] EAtARAB
`
`[12] RASA BAHRB
`
`[21] HRS 00107357. 5
`
`[51] Int. Cl’
`
`AG61K 35/78
`
`AG1P 27/06
`
`
`
`(43]437F8
`
`2001 4F 11 5 2848
`
`[21] BY 00107357. 5
`
`[22] Hi 2000.5.11
`[1] 8#RA AEB
`sant 050071 FILS HAETheH 28 SHR
`BESSTOR
`[72] RRA ADE
`
`([4]amee ATRRNAwASY
`[57] a
`RRAAH THATPERSOAS, Ee
`HATRREEILES AER: RAS 10-30 H,
`Hy 10 -30 } , HFEF 10 -30 4},10 -30 H, AR
`BA 15 —45 O}, BYE 15 -— 45 Oy, WE 15 -45 Oh, Bzb 10 -
`30 $f, HYRHA 15 - 45 4}, FAYT 10 -30 , KS 10 -30
`By HAE 10 - 30 Gy, SHAE 10 - 30 4}, RAAB 10 - 30
`O HES -25 ff ARBrHaAALI
`AER BOAF
`
`[11] 29F CN 1323595A
`
`(4]FHRBMA HISARSHH
`RA Ae
`
`ABR 1 Pi4 KO
`
`ISSN1008-4274
`
`$a 7Ah aHE Hh PR
`
`

`

`ene
`
`a
`
`l, —PPATSRMAAS, HRMEETCAATREERILER
`KER: KAZ 10-304, FIAJ10-306, #425 10-306), BEX 10—304},
`FRA IS-454}, FQRE15S-4563, BEA IS—454, 394610—30¢3, Bi yp ad 1s—a5
`tt, AT 10-306}, %B10-304), M4HF10-304}, BF2016,10-304, PCARRD 10
`306}, HELS-2544,
`2, PRGAABES | IRASay, PILECOAFRESAL
`ESOTRRA: PIS 15-20), GAz1S-2045, MACF20-30}, BX20—30
`tt, AiRHA25-306}, FQRE15-204), KeA 15—30¢, 3§7E20—306}, Bryh030
`Ast, ERT 10-206}, ZH20-30G), WAK15-2045, HFBe7620-306), AC HA
`Wb20-304), +H 2220-254},
`
`

`

`as mane
`
`AP GRR ZAa
`
`AS RASeA IRRRAk BD, Aa zeA P24 Hh
`
`e110 BAA Pie ry a CHRA
`
`Fy GH rs BE PEAR RTT re PR EP. L.ARI. AE
`
`
`FEAR RAPES tr, Fe REE IE Aee EPS. PLR, FETE
`
`BUR, ATOR VERA. ERBCS ERI» PRET Ub i LA BA ee LAY
`
`RAARUT BIR. RE SU NEARRAD a oS, BOTA
`
`AAG, ZERKA A, APARIEAKEM, MAPA A SRA AA, AATILA
`
`Hy, FAK AAS MD AD AS TG FE KL Bit Ac Tim IN Ja ee BES A ESLER AE, EA
`
`A, HAE, PRR. RR, WUTARR SE. WRAL CHE
`
`Ala. RG. ERMC: TER, RA ERICK, RAK R, HARES
`
`
`Af, AURA, DUO SRO BE. DaWeel, iPM. ARI
`
`ARTA, R2MAAP RM ei, MPLA MMA, Be
`
`MLS PETMLA, BPR, MAAS REA, FMR
`
`feb AoARES RA Roe,
`
`IRA A “REE” CCIE YR EAR
`
`351) ) alate, SIR, TRIKAKA, Blah. HAE Be re Fi Al ab a
`
`iB, eR, ATH, “ULE, GARE, beak, HAPBUHE, Bt
`
`HERI, JRE, ARPES, BERLE, BURA, ENT A. SABA
`
`FARR EZ RAVE, MRT ASK, BA, SKER AIG, PAR
`
`io ERIN ARAKI AK, SH ONES, HAAR HME ReA Ah, AM
`
`i. CSAAARIERKRBAT RE, PRARBYS ABTA, MUKA AK.
`
`ETaR, DSR AE. MRNCRAA RSA A, WA
`
`LE PAS RIB) 1%--2%0)CFEAAI, LARIMER, ZeRPETR, PP eT EREAR
`
`

`

`BAR, PUASITABLL, REARARIE, ULBEe
`FAAREARAEIREHR BOR A, AT, thaRE Ozh.
`FEIMARTATE F, PRES RAP. MET. HOR. 249, RAS. 5, GR, be
`AEBAY PLVEECL CA BBBE) )
`, BER RAB EE, Abu, “4ya, BeaR,
`AGE. PRIS. AMI. MS. BS. HAARRRS OL (ERS
`Se)
`) REATIOIT, SSRANS}AB
`
`ASAI A HUBAeEEEAEBMLRBO
`i .
`
`ARROW AAD AROPESEELIN, SEFRAS REERTPSHE CEUARUAB, PERL
`PYRE) ACBLETAITFAI, MPRA ARAL, BAPE. Be
`KR. mAK, RBH,RAY 10-300}, AAi10-304, #Z10—30
`Gr, MALL 10-306}, FERHGIS-456), ARIF10-306}, %B10-306}, BHAF10
`SOG, BBE 110-306), ACBLHD 10-304}, H 5-254}, Fam IS—a5¢), GyeaR
`15—454, Wi 15—454}, 487610304}.
`
`ASBe WA AYOickBeaA Lb
`RE15-2067, FAV1S-206}, BR20—30H}, MAI20-306}, AYU 25-
`306, FARR IS-206), BEA15-206), 397E20-306),
`EV RAH30-45¢}, 4BFF 10-
`204, KB20-30}, FAL 15-20G), BFS24E20-304}, PLAHRP20-304}, +2220
`-25}
`
`ABW ADT iSBOK A. BREA. CARB.ph ORAS
`ARSC 2D) tl] SeIEHI
`L, BARAT PIA EPRIAS}, DTKM2-4it, AACI-2/h at,
`WE, PUGSHt, WEILIREBR, WEE, BYR, 80
`A -100F fii, JGRAIEEE, RERIBCEP 70.3225H).
`ASSN PS0HilCESBEAUEETPEGIEEE: UCDO, 4
`
`

`

`~e ane
`
`aon
`
`ae
`
`el
`
`A= ik, SiRAITRE.
`ASBe WARSBE ra TE FSRSe, BAT BOER. ak
`BWAieAV. RRB. 387k. PAAR, MBA. ERT. WK
`WD. CRBALRMABUB ATM, KS. BHI. SEE. fae
`F. A, HACE, TRAS. AA, GONBA
`“UL -#METaaFFM D3. ER. SAU, YSU, te
`Bik, SiDRL RELAgSEESAT HFTAK.
`
`ABW 29)AASP BF SEAKAEEN. EH
`tRT ARCA YT Sm. PEFR PEZA AUER
`
`ASA & 28 OCGA EEG Fl, EEME
`ABCAOYAfatRESat13.2Bi RH A ABE IMREBB TE
`ASB AADTS STATE YK A:
`
`| TREEErithARRGH2s AHE 132A GTRMELA BRE BE HH:
`a
`FELLA RAPT7E A JaBD OIG TSBTRAB IA EEE) +)
`
`TY BONE :
`
`AW: WRK, FORK, RRRIER.
`
`Ofee: HR RATPB.
`
`FOB: IRAEAR
`
`SE SRL PR:
`
`
`
`
`
`
`
`
`
`
`
`
`
`DAB xeAS Ac HYA SEBi
`
`SK iti Hl 1:
`
`MRR S30kg, AAlOkg, HX2Wkg, MiAF20kg, Avei4skg, AH
`I5kg,
`faeA20kg, A4E2kg, HRM Ske, ARTF2Okg, KH30kg, AA
`
`

`

`I5kg, 3ctk20kg, RAM W1Ske, HH20ke, HAA, IIIA, H
`AUD, GE, ZORA, ZAMRADI, SOPRA, TRB
`FR, BEF, Bean. TSO Si, HeeAURORE3ETON.
`CAP SEE BI2-6, SHRES Sc BL, RS A AL a OS
`[a], (AREABIARe BA TAY A SR.
`
`SE Wee fi]2—6:
`
`
`
`“|giy
`
`RAS
`
`Ut ot
`
`Mt F
`
`Atk AH
`
`SF ot
`
`ww
`
`weuw—o
`
`— o
`
`3
`
`15
`
`BE ae TE
`
`Ac BA
`
`at a
`
`Wi TE
`
`
`i.
`
`
`
`wmloels
`
`
`—_adfeeetnoS
`+Wa
`
`tadSoSo
`taho na
`
`
`BR)oo‘afoS]GS]wu
`nNSota]&
`wl]we o
`~|-a|wt
`
`Tht+ta||&ie.
`
`bowneSo2oSoS
`
`
`
`
`
`
`
`
`
`wep—|]wR]Reol]loya
`Be|RtmM]®
`bobondLaLn
`WwW]MeOo]
`
`
`
`
`
`
`
`La
`
`bo ta
`
`Us
`
`botn
`
`—_ an
`
`— La
`
`i) a
`
`— Uh
`
`N
`
`5
`
`—
`
`Ne
`
`20
`
`Ww
`
`-_
`
`No
`
`we
`
`No CA
`
`to
`
`nh
`
`o
`
`ws
`
`_
`
`_
`
`oS
`
`— So
`
`wNy
`
`ww oS
`
`=
`
`bo
`
`bo
`
`ho
`
`a
`
`o
`
`tad
`
`— tun
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket